Cowen and Company’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,355
| Closed | -$267K | – | 570 |
|
|
2022
Q4 | $267K | Sell |
2,355
-3,740
| -61% | -$424K | 0.03% | 149 |
|
|
2022
Q3 | $491K | Buy |
+6,095
| New | +$491K | 0.05% | 122 |
|
|
2022
Q2 | – | Sell |
-6,256
| Closed | -$800K | – | 577 |
|
|
2022
Q1 | $800K | Buy |
6,256
+2,160
| +53% | +$276K | 0.08% | 112 |
|
|
2021
Q4 | $550K | Buy |
+4,096
| New | +$550K | 0.05% | 193 |
|
|
2021
Q2 | – | Sell |
-14,284
| Closed | -$1.28M | – | 432 |
|
|
2021
Q1 | $1.28M | Buy |
+14,284
| New | +$1.28M | 0.09% | 110 |
|